Herein, the current study tested the hypothesis that modulation of TGF-β1/p-Smad/p21 signaling by memantine, rosuvastatin and their combination and their effect on BBB transporters that govern Aβ clearance and their regulating miRNAs may provide therapeutic potential against AD. The gene discussed is TGFB1; the disease is Alzheimer disease.